The association of asthma and atrial fibrillation - A nationwide population-based nested case-control study

International Journal of Cardiology

Volumn 176, Issue 2, 2014, Pages 464-469

  Chan, Wan Leong ^a,b   Yang, Kun Pin ^a   Chao, Tze Fan ^a   Huang, Chin Chou ^a,b   Huang, Po Hsun ^a,b   Chen, Yu Chun ^a,b   Chen, Tzeng Ji ^a,b   Lin, Shing Jong ^a,b   Chen, Jaw Wen ^a,b   Leu, Hsin Bang ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Asthma; Atrial fibrillation; Corticosteroid; Population based nested case control study

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID;

ADULT; AGED; ARTICLE; ASTHMA; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; TAIWAN; ATRIAL FIBRILLATION; CASE CONTROL STUDY; CHEMICALLY INDUCED; COHORT ANALYSIS; HEALTH SURVEY; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PROCEDURES; VERY ELDERLY;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; ASTHMA; ATRIAL FIBRILLATION; BRONCHODILATOR AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; TAIWAN;

EID: 84922414756     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.087     Document Type: Article

References (48)

1. Wolf PA,Mitchell JB, Baker CS, KannelWB, D'Agostino RB. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998; 158: 229-34.
2. Lloyd-Jones DM,Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation Aug. 31 2004; 110(9): 1042-6.
3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946-52.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-8.
5. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation Dec. 16 2003; 108(24): 3006-10.
6. Schnabel RB, Larson MG, Yamamoto JF, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 2010; 121(2): 200-7.
7. Hsieh KH, Shen JJ. Prevalence of childhood asthma in Taipei, Taiwan, and other Asian Pacific countries. J Asthma 1988; 25: 73-82.
8. Asher MI, Montefort S, Björkstén B, et al. ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368(9537): 733-43.
9. Murphy DM, O'Byrne PM. Recent advances in the pathophysiology of asthma. Chest June 2010; 137(6): 1417-26.
10. Riedl MA, Nel AE. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol 2008; 8: 49-56.
11. Vignola AM, Kips J, Bousquet J. Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 2000; 105: 1041-53.
12. Ahmad A, Shameem M, Husain Q. Relation of oxidant-antioxidant imbalance with disease progression in patients with asthma. Ann Thorac Med 2012; 7(4): 226-32.
13. Iribarren C, Tolstykh IV, Miller MK, Sobel E, Eisner MD. Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: A prospective study of 2 matched cohorts. Am J Epidemiol 2012; 176(11): 1014-24.
14. Iribarren C, Tolstykh IV, Eisner MD. Are patientswith asthma at increased risk of coronary heart disease? Int J Epidemiol 2004; 33: 743-8.
15. Onufrak S, Abramson J, Vaccarino V. Adult-onset asthma is associated with increased carotid atherosclerosis among women in the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2007; 195: 129-37.
16. Onufrak SJ, Abramson JL, Austin HD, Holguin F, McClellan WM, Vaccarino LV. Relation of adult-onset asthma to coronary heart disease and stroke. Am J Cardiol 2008; 101: 1247-52.
17. Vijayakumar J, Subramanian S, Singh P, et al. Arterial inflammation in bronchial asthma. J Nucl Cardiol 2013; 20(3): 385-95.
18. van der Hooft CS, Heeringa J, Brusselle GG, et al. Corticosteroids and the risk of atrial fibrillation. Arch Intern Med 2006; 166(9): 1016-20.
19. Chou KT, Huang CC, Chen YM, et al. Asthma and risk of erectile dysfunction -A nationwide population-based study. J Sex Med 2011; 8(6): 1754-60.
20. Warnier MJ, Rutten FH, Kors JA, et al. Cardiac arrhythmias in adult patients with asthma. J Asthma 2012; 49(9): 942-6.
21. Ferreira RC, Freitag DF, Cutler AJ, et al. Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases. PLoS Genet Apr. 2013; 9(4): E1003444.
22. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-4.
23. Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: Postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997; 96(10): 3542-8.
24. Lin YJ, Tsao HM, Chang SL, et al. Prognostic implications of the high-sensitive Creactive protein in the catheter ablation of atrial fibrillation. Am J Cardiol 2010; 105(4): 495-501.
25. Liu T, Li G, Li L, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: A meta-analysis. J Am Coll Cardiol 2007; 49: 1642-8.
26. Siu CW, Lau CP, Tse HF. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol 2003; 92: 1343-5.
27. Young-Xu Y, Jabbour S, Goldberg R, et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 2003; 92(12): 1379-83.
28. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984; 39: 131-6.
29. RocheWR, Beasley R,Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1: 520-4.
30. Brundel BJ, Van Gelder IC, Henning RH, et al. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 2001; 103(5): 684-90.
31. Nakano Y, Niida S, Dote K, et al. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J Am Coll Cardiol 2004; 43(5): 818-25.
32. Mattos W, Lim S, Russell R, Jatakanon A, Chung KF, Barnes PJ. Matrix metalloproteinase-9 expression in asthma: Effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest 2002; 122: 1543-52.
33. Nadeem A, Raj HG, Chhabra SK. Increased oxidative stress in acute exacerbations of asthma. J Asthma 2005; 42: 45-50.
34. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007; 115: 135-43.
35. MacPherson JC, Comhair SA, Erzurum SC, et al. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: Characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol 2001; 166(9): 5763-72.
36. Eiserich JP, Hristova M, Cross CE, et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391(6665): 393-7.
37. Kim YH, Lim DS, Lee JH, et al. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med Oct. 31 2003; 35(5): 336-49.
38. Neuman RB, Bloom HL, Shukrullah I, et al. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem Sep. 2007; 53(9): 1652-7.
39. Christiansen CF, Christensen S, Mehnert F, Cummings SR, Chapurlat RD, Sørensen HT. Glucocorticoid use and risk of atrial fibrillation or flutter: A population-based, case-control study. Arch Intern Med 2009; 169(18): 1677-83.
40. Usmani OS. Treating the small airways. Respiration 2012; 84(6): 441-53.
41. Huerta C, Lanes SF, Garcia Rodriguez LA. Respiratory medications and the risk of cardiac arrhythmias. Epidemiology 2005; 16: 360-6.
42. Workman AJ. Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 2010; 381(3): 235-49.
43. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy. Stroke prevention in atrial fibrillation investigators. J Am Coll Cardiol 2000; 35: 183-7.
44. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston area anticoagulation trial for atrial fibrillation investigators. N Engl J Med 1990; 323: 1505-11.
45. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-57.
46. Gronroos NN, Alonso A. Diet and risk of atrial fibrillation -epidemiologic and clinical evidence. Circ J 2010; 74: 2029-38.
47. Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA Nov. 4 2004; 292(20): 2471-7.
48. Heeringa J, Kors JA, Hofman A, van Rooij FJ, Witteman JC. Cigarette smoking and risk of atrial fibrillation: The Rotterdam Study. Am Heart J 2008; 156: 1163-9.